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Summary 
We have studiεd the effect of MK733， a potent HMG COA reductas色 inhibitor，on syntheses 
and secretion of glycerolipids and stenols in HepG2 cels. HepG2 cells were cultured in DMEM 
with or without addition of lVIK -733 for up to 6 homs. Triacylglycerol and phospholipid synthεsεs 
wer日monitoredby the incorporation of [1 (3) -3HJ glycerol into在日chlipid fraction in HεpG2 cells， 
and sterol and fatty acid synthεses werεmonitored by using [1-14CJ acetatεas a trac邑r.
MK-733 depr巴ssedchol告sterolsynthesis in a dose-dependent mannor at conc巴ntrationsof 0.1 
μM to 10μM. Addition of lower concεntartion of th日drughad no influ巴nceon the synth巴sesof 
phospholipid and triacylglycerol， whereas a relatively higher concεntration of MK73:3 rεsulted in an 
significant increas日inphospholipid synthesis. The sp巴cificradioactivities (dpm/μg lipid) of 
triacylglycerol and phospholipid in thεcells were comparable with or without treatment of the 
drug， exc巴ptfor the cells treated with the drug at the concentration of 0.1μM. Secretion rate of 
[1 (3) -3HJ glyc日roHabel己dlipids to the medium was comparablεamong the groups. The data of 
the preset stucly sugg日stthat an addition of HMG CoA r日duct呂seinhibitor呂ta rεlatively high芭r




























細胞の総脂質は， Bligh and Dyer法叫こ従い抽出純化した.回収した細胞は 1m1!の生理会
塩水に懸濁後，その一部 (0.7mりを共栓付試旺管に取りメタノールを 2m1!加えて良く撹枠し，
クロロホルム 1孤立を加えて3TC，15分間加温した@その後，クロロホルム 1m1!と7.k0.9m1!加え













で濃縮した.それにエタノール性KOH(エタノー ノレ94mQに水:KOH 1 :1， v/w， 6m1!を混





























Table 1 Effect of 1¥1K -733 on concentrations of protein， phosphulipid and triglyceride in Hep G2 
cells 
Group Prutein Phospholipid Triglyc告rid巴
(mg/dish) (nmol/dish) (ねmol (nmo1/ dish) (nmol 
/mg cel pro.) /mg cel pro.) 
Control 0.82士0.06 164.5土2.0 184.9ニヒ13.4 47.6土2.4 53. 3:t 1.8 
lVIK -733 
0.1μ孔f 0.99土0.05 103.4土0.4 105.0土7.8 54.4土7.9 55.8士11.9 
0.1μM O. 98:tO. 04 177.0土12.7 180.8:t7.8 55.4土5.4 54.7土2.2
10μ1¥1 1.02土0.02* 212.1土16.1 207.5土20.8 66.5土4.0 65.0土5.5
Values are the mεans土S.E.()f 3 samples 








Table 2 Effect of MK--733 on the incorporation of [1-"C] acetate into cellular lipids of Hep G2 
C巴ls
Group Total Lipids PL DG FFA TG EC 
[14C] cpmX103!dish 
Control 158ごと14 95土12 12ごと1 7土0_3 31ニ1 4ごと0.2
MK-733 
0.1μM 191土l 113土2 13:1:0.2 6こと0.5 37:1:1 5-←0.3 
0.1μM 212土14 138:1:ヲ 13土O司5 6土l 43二と3 5ゴ:0.4
10μ孔f 257土1* 169:1:8本 13土l 8土l 57土8本車 5土0.2
[14CJ cpmXI0'!mg cell pro. 
Control 193土8 115土7 15こと2 8土1 38こと2 5:1こ0.3
MK-733 
0.1 flM 194土15 125:1: 1 13土1 6:土:0.1 37士2 5-士0.03
0.1μM 216土7 140:1:5 14土0.2 6土0.3 44:1 1 5ゴ二0.2
10μM 257土ゲ 165土12* 12土1 8土0.5 55土6 5土0.1
Values are th巴means土S.E.of 3 samples 
ぺ*キ， Differ significantly from the control旦tP<O.05 and P<0.01， respectively. 
Abbreviations used: PL， phospholipid; TG， triglyc巴ridε;DG， diglyceride; 
FF A， free fatty acid; EC， esterified cholesterol; FC， free cholesterol 
Tabl日3 Effect of MK-733 on the phospholipid composition of Hep G2 cells 
Group LPC SPH PC ドI土PS PE 
% of total [引]cpm 
Control 0.49:1ニ0.08 1. 93土0.25 63.82:土0.48 13.75土0.47 16.97土0.45
MK-733 
0.1cμM 0.51土0.23 2.18土0.13 64.28土l.56 14.04士0.93 16.43土0.70
0.1μM 0.34:1:0.11 2. 32:tO .12 64.70土0.57 13.59土0.52 16.49土O司10
10μM 。‘41土0.13 l.78:tO.19 65.50土0.38 13.49土0.23 16.45土0.15
% of total L l4CJ cpm 
Control 0.58土0.21 1.67土0.28 69.37土0.09 12.49土0.40 13.43士0.16
MK733 
0.1μM 。司64土0.19 1.92土0.09 69.91土0.49 12.14土0.82 13.35..士0.02
0.1μM 。合35土0.07 2.32:t0.15 70.52士0.17 11.8ヲ:とO‘1 12.98:1二0.19
10μM 0.36土0.22 2.15土0.08 71.48土0.69キ 11.42土0.34 12.82 I 0.47 
Valu巴sare the means土S.E.of 3 samples. 
ペホへ Diff日rsignificantly from th巴controlat PくO司05and Pく0.01，resp巴ctively.
Abbr巴viationsused: LPC， lysophosphatidylcholine: SPH， sphingomyelin; 
Pc， phosphatidylcholine; PI， phosphatidylinositol; PS， phosphatidylsεrme; 




















Tab!e 4 Effect of MK -733 on the incorporation of [1> 14CJ acεtate into 
unsaponifab!e materia!s of Hep G2 cells 
Group Total USM Cho!estero! Lanosterol Squalen官
[14C1 cpmX103/dish 
Control !O .55:10.62 7.56土0.23 2.46:10.20 0.54土0.20
MK 733 。1μM 8.67コヒ0.44 6.41i:0.21 1.59土0.20 0.64土O‘03
0.1μlVI 7.2)3二七0.32 4.87土0.00ホ本 l. 68こ土0.34 0.99:10.01 
10μM 7‘17二と1.43 o. 7:l士0.43村 4.64土0.10キ* 1. 81土0.9官
[14CJ cpm X 103/mg cell pro 
Control 11.82士0.29 8.49土0.46 2.75土0.01
MK 733 
0.1μM 8.83土l.07 6.52:10.68 1..3士0.32
0.1μM 7.46:10.12 4.84土0.29* 1. 65士0.24
10μM 7.04土1.57 0.73:10.44ネホ 4.54二七0.21*





へ傘へ Differsignificantly from the contro!呂tPく0.05and P<O.OI， respective!}ヘ
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Table 5 Effect of MK-733 0ロtheincorporation of [1 (3) 3HJ glycerol into 






Phospholipids Diglycerid日S Triglycerides 
['HJ cpm X l()'l/ dish 
30.8土3.1 2.5:士:0田2 6.3土0.1






0.1μM 51.7士:2.3** 41‘8:l 1. 9* 
10μM 61.3ごと0.8* 49.8土2.2叫




















9.1 :l0. 9 
Values are th巴means土S.E.of 3 samples 
へキペ Differ・51宮nificantlyfrom the control at Pく0.05and P<O.OI， rεspectively 
不ケン化物への取り込みから 9
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Table 6 Effect of MK -733 on the specific radio activ-
































Valuεs ar巴themeans土S.E.of 3 samples 




















Fig‘1 Effect of MK 733 on total lipid s巴cretionto Hep G2 medium 








に及ぼす影響を HepG2細胞系でト検討した. HepG2細胞は MK…733を合干ぎする DMEM培地中









1) Alexandar， C.A.， Hamilton町R.L.and Havel， R.J.ー ].CellBiol. 69， 241 263 (1976) 
2) Wong， L.and Pino， R.M.: Eur. J. Biochem.， 164， 357-367 (1987) 
3) Siuta-Mangano， P.and Lane， M.D・J.Biol.Chem.， 256， 2094~2097 (1981) 
4) Janero， D.R.and Lan巴， M.D・].Biol.Chem.，258， 144吉6-14504(1983) 
5) Yanagita， T.， Yamamoto， K. and Ishida， S.: Ther呂 Res.in pr巴s (1994) 
6 )尊田和美子:佐賀大学大学院農学研究科修士論文 1994年3月
7 )山本庄介，福島範五堺i塗弘，柳田晃主主:Prog. M吋， 1， 432 (19幻)
8) Bligh， E.G. and Dyer乃A!.]・Can.J. Biochem， Physiol.， 31， 911~917 (1959) 
9) Yanagita， T守 Satoh，M汁 Enomoto、N.and Sugano， M: Biochim. Biophy. Acta，幻自， 64 70 (1987) 
10) Yanagita， T.， Kobayashi， K. and Enomoto， N.: Biochem. Ph呂rmacol.， 27， 2283~2288 (1978) 
11) Smith， P.K.: Anal. Biochem“ 150， 76 (1985) 
